These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29480231)

  • 21. Simple and Complex Sugars in Parkinson's Disease: a Bittersweet Taste.
    Zulueta A; Mingione A; Signorelli P; Caretti A; Ghidoni R; Trinchera M
    Mol Neurobiol; 2020 Jul; 57(7):2934-2943. PubMed ID: 32430844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links.
    Groener JB; Oikonomou D; Cheko R; Kender Z; Zemva J; Kihm L; Muckenthaler M; Peters V; Fleming T; Kopf S; Nawroth PP
    Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):497-504. PubMed ID: 28407670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
    Vicente Miranda H; Szego ÉM; Oliveira LMA; Breda C; Darendelioglu E; de Oliveira RM; Ferreira DG; Gomes MA; Rott R; Oliveira M; Munari F; Enguita FJ; Simões T; Rodrigues EF; Heinrich M; Martins IC; Zamolo I; Riess O; Cordeiro C; Ponces-Freire A; Lashuel HA; Santos NC; Lopes LV; Xiang W; Jovin TM; Penque D; Engelender S; Zweckstetter M; Klucken J; Giorgini F; Quintas A; Outeiro TF
    Brain; 2017 May; 140(5):1399-1419. PubMed ID: 28398476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on prevention of glycation of proteins: Potential therapeutic substances to mitigate the severity of diabetes complications.
    Sarmah S; Roy AS
    Int J Biol Macromol; 2022 Jan; 195():565-588. PubMed ID: 34920073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.
    Kurz A; Rabbani N; Walter M; Bonin M; Thornalley P; Auburger G; Gispert S
    Cell Mol Life Sci; 2011 Feb; 68(4):721-33. PubMed ID: 20711648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.
    Chen L; Wei Y; Wang X; He R
    PLoS One; 2010 Feb; 5(2):e9052. PubMed ID: 20140223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-translational modification of α-synuclein in Parkinson's disease.
    Barrett PJ; Timothy Greenamyre J
    Brain Res; 2015 Dec; 1628(Pt B):247-253. PubMed ID: 26080075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein.
    Atieh TB; Roth J; Yang X; Hoop CL; Baum J
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms.
    König A; Outeiro TF
    J Parkinsons Dis; 2024; 14(5):917-924. PubMed ID: 38995799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein Repair from Glycation by Glyoxals by the DJ-1 Family Maillard Deglycases.
    Mihoub M; Abdallah J; Richarme G
    Adv Exp Med Biol; 2017; 1037():133-147. PubMed ID: 29147907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bimolecular interaction of argpyrimidine (a Maillard reaction product) in in vitro non-enzymatic protein glycation model and its potential role as an antiglycating agent.
    Bhattacherjee A; Dhara K; Chakraborti AS
    Int J Biol Macromol; 2017 Sep; 102():1274-1285. PubMed ID: 28487198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's Disease: Alpha Synuclein, Heme Oxygenase and Biotherapeutic Countermeasures.
    Haines DD; Trushin MV; Rose S; Bernard IAS; Mahmoud FF
    Curr Pharm Des; 2018; 24(20):2317-2321. PubMed ID: 30019639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycation of α-synuclein amplifies the binding with glyceraldehyde-3-phosphate dehydrogenase.
    Semenyuk P; Barinova K; Muronetz V
    Int J Biol Macromol; 2019 Apr; 127():278-285. PubMed ID: 30658140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications.
    Elosta A; Ghous T; Ahmed N
    Curr Diabetes Rev; 2012 Mar; 8(2):92-108. PubMed ID: 22268395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycotoxines, carbonyl stress and relevance to diabetes and its complications.
    Turk Z
    Physiol Res; 2010; 59(2):147-156. PubMed ID: 19537931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications.
    Abbas G; Al-Harrasi AS; Hussain H; Hussain J; Rashid R; Choudhary MI
    Pharm Biol; 2016; 54(2):198-206. PubMed ID: 25853955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitration and Glycation Diminish the α-Synuclein Role in the Formation and Scavenging of Cu
    Martínez-Orozco H; Mariño L; Uceda AB; Ortega-Castro J; Vilanova B; Frau J; Adrover M
    ACS Chem Neurosci; 2019 Jun; 10(6):2919-2930. PubMed ID: 30973706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.
    Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE
    J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maillard Proteomics: Opening New Pages.
    Soboleva A; Schmidt R; Vikhnina M; Grishina T; Frolov A
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29231845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.